Crossmark

Dacarbazine nanoparticle topical delivery system for the treatment of melanoma

Crossref DOI link: https://doi.org/10.1038/s41598-017-16878-1

Published Online: 2017-11-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hafeez, Abdul

Kazmi, Imran https://orcid.org/0000-0003-1881-5219
License Information

Text and Data Mining valid from 2017-11-28

Version of Record valid from 2017-11-28
More Information

Article History

Received: 21 September 2017

Accepted: 17 November 2017

First Online: 28 November 2017

Competing Interests

: The authors declare that they have no competing interests.